Shandong Weigao Orthopaedic Device Co. Ltd. A (SHG:688161) — Market Cap & Net Worth
Market Cap & Net Worth: Shandong Weigao Orthopaedic Device Co. Ltd. A (688161)
Shandong Weigao Orthopaedic Device Co. Ltd. A (SHG:688161) has a market capitalization of $1.67 Billion (CN¥11.40 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #6984 globally and #1628 in its home market, demonstrating a -9.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Weigao Orthopaedic Device Co. Ltd. A's stock price CN¥28.51 by its total outstanding shares 400000000 (400.00 Million). Analyse cash efficiency ratio of Shandong Weigao Orthopaedic Device Co. L to see how efficiently the company converts income to cash.
Shandong Weigao Orthopaedic Device Co. Ltd. A Market Cap History: 2021 to 2026
Shandong Weigao Orthopaedic Device Co. Ltd. A's market capitalization history from 2021 to 2026. Data shows change from $3.62 Billion to $1.67 Billion (-23.26% CAGR).
Shandong Weigao Orthopaedic Device Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Weigao Orthopaedic Device Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.02x
Shandong Weigao Orthopaedic Device Co. Ltd. A's market cap is 1.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.60x
Shandong Weigao Orthopaedic Device Co. Ltd. A's market cap is 6.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $3.62 Billion | $2.15 Billion | $690.32 Million | 1.68x | 5.25x |
| 2022 | $3.00 Billion | $2.06 Billion | $600.70 Million | 1.46x | 5.00x |
| 2023 | $2.41 Billion | $1.28 Billion | $112.32 Million | 1.87x | 21.42x |
| 2024 | $1.48 Billion | $1.45 Billion | $223.75 Million | 1.02x | 6.60x |
Competitor Companies of 688161 by Market Capitalization
Companies near Shandong Weigao Orthopaedic Device Co. Ltd. A in the global market cap rankings as of May 7, 2026.
Key companies related to Shandong Weigao Orthopaedic Device Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $150.06 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $111.87 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #246 globally with a market cap of $99.67 Billion USD ( €85.25 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $150.06 Billion | $86.30 |
| #211 | Stryker Corporation | NYSE:SYK | $111.87 Billion | $292.33 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #246 | Medtronic PLC | XETRA:2M6 | $99.67 Billion | €66.40 |
Shandong Weigao Orthopaedic Device Co. Ltd. A Historical Marketcap From 2021 to 2026
Between 2021 and today, Shandong Weigao Orthopaedic Device Co. Ltd. A's market cap moved from $3.62 Billion to $ 1.67 Billion, with a yearly change of -23.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.67 Billion | +2.11% |
| 2025 | CN¥1.63 Billion | +10.71% |
| 2024 | CN¥1.48 Billion | -38.63% |
| 2023 | CN¥2.41 Billion | -19.87% |
| 2022 | CN¥3.00 Billion | -17.14% |
| 2021 | CN¥3.62 Billion | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Shandong Weigao Orthopaedic Device Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.67 Billion USD |
| MoneyControl | $1.67 Billion USD |
| MarketWatch | $1.67 Billion USD |
| marketcap.company | $1.67 Billion USD |
| Reuters | $1.67 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Weigao Orthopaedic Device Co. Ltd. A
Shandong Weigao Orthopaedic Device Co., Ltd. operates as a orthopedic implant medical device and pharmaceutical company. The company offers general consumables, such as clinical care consumables and supplies, infection protection supplies, infusion consumables, indwelling needle, anesthesia respiratory consumables, other operating room consumables, and other clinical consumables; endocrine consum… Read more